Plan5500

Regeneron Pharmaceuticals, Inc. 401(K) Savings Plan — Form 5500 plan (Regeneron Pharmaceuticals, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Regeneron Pharmaceuticals, Inc. 401(K) Savings Plan is a benefit plan reported by Regeneron Pharmaceuticals, Inc. under EIN 13-3444607 and plan number 001. The latest loaded filing year is 2023. The filing reports 11,675 participants and $2,247,714,975 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Regeneron Pharmaceuticals, Inc.
EIN
13-3444607
Plan number
001
Plan type
2
Location
Tarrytown, NY
Latest filing year
2023
Participants
11,675
End-of-year plan assets
$2,247,714,975

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
202311,675H, C20240920081306NAL0004273571001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$2,247,714,975
Total liabilities (EOY)
$12
Net assets (EOY)
$2,247,714,963
Net assets (BOY)
$1,687,541,027

Income & contributions

Employer contributions
$73,353,990
Participant contributions
$177,378,414
Total contributions
$277,891,972
Total income / additions
$641,292,607

Expenses & distributions

Benefits paid
$80,504,235
Administrative expenses
$548,754
Total expenses
$81,118,671
Net increase / (decrease)
$560,173,936

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Fidelity Investments InstitutionalRECORDKEEPER$445,419$02023
Capfinancial Partners, LLCINVESTMENT ADVISOR$92,060not reported in the loaded dataset2023
Crowe LlpACCOUNTANT\AUDITOR$14,088not reported in the loaded dataset2023

Related Form 5500 pages